Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats

European Journal of Neuroscience

Volumn 12, Issue 11, 2000, Pages 3823-3832

  Anichtchik, Oleg V ^a,b   Huotari, Marko ^c   Peitsaro, Nina ^a   Haycock, John W ^d   Männistö, Pekka T ^c   Panula, Pertti ^a,e  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d LOUISIANA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

GTP 35S autoradiography; H3 receptor binding; Immunohistochemistry; Parkinson's disease

Indexed keywords

GUANOSINE TRIPHOSPHATE; HISTAMINE; HISTIDINE DECARBOXYLASE; OXIDOPAMINE; TRITIUM; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HISTAMINE H3 RECEPTOR; SULFUR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CADAVER; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; AMYGDALOID NUCLEUS; ANIMAL; BRAIN; CORPUS STRIATUM; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEMISPHERIC DOMINANCE; HUMAN; HYPOTHALAMUS; IN SITU HYBRIDIZATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SUBSTANTIA NIGRA; WISTAR RAT;

AMYGDALA; ANIMALS; BRAIN; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HISTAMINE; HISTIDINE DECARBOXYLASE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; RECEPTORS, HISTAMINE H3; SUBSTANTIA NIGRA; SULFUR RADIOISOTOPES; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

EID: 0033623459     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00267.x     Document Type: Article

References (45)

1. An altered histaminergic innervation of the substantia nigra in Parkinson's disease
2. 3) of histamine receptor
3. A primate model of parkinsonism. Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
4. The distribution of histidine decarboxylase mRNA in the rat brain. An in situ hybridization study using synthetic oligonucleotide probes
5. Histamine and spontaneous motor activity: Biphasic changes, receptors involved and participation of the striatal dopamine system
6. 3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin
7. Cerebral histamine levels are unaffected by MPTP administration in the mouse
8. 3 receptor characterization and autoradiographic localization in rat brain
9. 3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata
10. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
11. 3-receptor binding in the normal human basal ganglia. Comparison with Huntington's and Parkinson's disease cases
12. Quantification of tyrosine hydroxylase, protein levels. Spot immunolabeling with an affinity-purified antibody
13. 3 antagonist, in a light/dark test in mice
14. 3-receptor antagonist, in a light/dark test measuring anxiety in mice
15. An analysis of histaminergic efferents of the tuberomammillary nucleus to the medial preoptic area and inferior colliculus of the rat
16. Effects of histamine agents on methamphetamine-induced stereotyped behavior and behavioral sensitization in rats
17. Characterization and expression of the complementary DNA encoding rat histidine decarboxylase
18. Lack of histamine synthesis and down-regulation of H1 and H2 receptor mRNA levels by dexamethasone in cerebral endothelial cells
19. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations
20. 3 receptor-dependent G protein activation in rat brain tissue sections
21. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis
22. Increased expression of glutamic acid decarboxylase mRNA in rat substantia nigra after an ibotenic acid lesion in the caudate-putamen
23. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model
24. L-glutamic acid decarboxylase in Parkinson's disease: Effect of L-dopa therapy
25. 3 receptor
26. Central effects of histamine and H1 and H2 receptors agonists and antagonists after intraventricular infusion in fowls
27. Increased expression of 5HT2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway
28. Neuropharmacology of the histaminergic neuron system in the brain and its relationship with behavioral disorders
29. Histamine-immunoreactive nerve fibers in the rat brain
30. Histamine-containing neurons in the rat hypothalamus
31. The rat brain in stereotaxic coordinates (2nd edn)
32. A. 6-hydroxydopamine-induced selective parkinsonian rat model
33. 3 receptors in rat brain areas
34. A. parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP
35. 3 histamine receptors
36. Modulation of GFAP mRNA levels following toxic lesions in the basal ganglia of the rat
37. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum. Implications for human Parkinson's disease
38. 2 receptors
39. 3 receptors in the striatum and substantia nigra after 6-hydroxydopamine-induced denervation of dopaminergic neurons. An autoradiographic study
40. 3-receptors following destraction of the ascending dopaminergic neurones
41. Reduction of cortical dopamine, noradrenaline, serotonin, and their metabolites in Parkinson's disease
42. Ontogeny of D1A and D2 doparnine receptor subtypes in rat brain using in situ hybridization and receptor binding
43. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding
44. Cardiovascular and behavioural changes after i.c.v. infusions of histamine and agonists in conscious goat
45. 3 receptor antagonist, increases GABA release from the rat hypothalamus